Clinical trial reportThe British journal of dermatologyPublished
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The British journal of dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Psoriasis; Dermatologic Agents; Antibodies, Monoclonal; Body Surface Area; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Aged; Middle Aged; Female
- PubMed ID
- 40875818
- Added to directory
- Source checked